Abstract | BACKGROUND: METHODS: Effects of combination therapy with canagliflozin and pioglitazone were evaluated in established diabetic KK-Ay mice and prediabetic Zucker diabetic fatty (ZDF) rats. RESULTS: CONCLUSIONS:
|
Authors | Yoshinori Watanabe, Keiko Nakayama, Nobuhiko Taniuchi, Yasushi Horai, Chiaki Kuriyama, Kiichiro Ueta, Kenji Arakawa, Takaaki Senbonmatsu, Masaharu Shiotani |
Journal | PloS one
(PLoS One)
Vol. 10
Issue 1
Pg. e0116851
( 2015)
ISSN: 1932-6203 [Electronic] United States |
PMID | 25615826
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Hypoglycemic Agents
- Thiazolidinediones
- Canagliflozin
- Pioglitazone
|
Topics |
- Adipose Tissue
(drug effects)
- Animals
- Body Weight
(drug effects)
- Canagliflozin
(administration & dosage, therapeutic use)
- Cells, Cultured
- Diabetes Mellitus, Experimental
(drug therapy)
- Drug Therapy, Combination
- Hyperinsulinism
(chemically induced, drug therapy)
- Hypoglycemic Agents
(administration & dosage, therapeutic use)
- Mice
- Obesity
(chemically induced, drug therapy)
- Pioglitazone
- Rats
- Rats, Zucker
- Thiazolidinediones
(administration & dosage, therapeutic use)
|